Abiopharma

New Form 8-K - Chicago Atlantic BDC, Inc. Filed: 2025-06-27 AccNo: 0000950103-25-007987 Size: 196 KB Item 5.07: Submission of Matters to a Vote of Security Holders Item 9.01: Financial Statements and Exhibits

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Altimmune, Inc. - ALT

Rosen Law Firm Urges Sarepta Therapeutics, Inc. (NASDAQ: SRPT) Stockholders with Large Losses to Contact the Firm for Information About Their Rights

RetinalGenix Technologies Contracts with LabCorp to Support DNA/GPS Platform for Advanced Genetic and Retinal Health Screening

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Emily in Paris Season 5: Everything We Know So Far

New Form 11-K - TELEFLEX INC Filed: 2025-06-27 AccNo: 0000096943-25-000104 Size: 206 KB

New Form 11-K - Merck & Co., Inc. Filed: 2025-06-27 AccNo: 0001628280-25-033262 Size: 236 KB

New Form 11-K - Merck & Co., Inc. Filed: 2025-06-27 AccNo: 0001628280-25-033255 Size: 223 KB

New Form 11-K - Merck & Co., Inc. Filed: 2025-06-27 AccNo: 0001628280-25-033252 Size: 223 KB

New Form 11-K - Fresenius Medical Care AG Filed: 2025-06-27 AccNo: 0001104659-25-063533 Size: 253 KB

Zentek Provides Regulatory Update on ZenGUARD™ Enhanced Air Filters

New Form 11-K - METTLER TOLEDO INTERNATIONAL INC/ Filed: 2025-06-27 AccNo: 0001037646-25-000033 Size: 221 KB

New Form 6-K - BetterLife Pharma Inc. Filed: 2025-06-27 AccNo: 0001477932-25-004829 Size: 965 KB